| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/03/2015 | US8946204 Substituted phenylureas and phenylamides as vanilloid receptor ligands |
| 02/03/2015 | US8946203 Benzodioxane inhibitors of leukotriene production |
| 02/03/2015 | US8946202 Substituted porphyrins |
| 02/03/2015 | US8946201 Methods for inhibiting TGF-β |
| 02/03/2015 | US8946200 Pharmaceutically active nanosuspensions |
| 02/03/2015 | US8946199 Co-administration of steroids and Zoledronic acid to prevent and treat side effects from Zoledronic acid infusion |
| 02/03/2015 | US8946198 Estrogen replacement regimen |
| 02/03/2015 | US8946197 Transglutaminase TG2 inhibitors, pharmaceutical compositions, and methods of use thereof |
| 02/03/2015 | US8946195 Bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators |
| 02/03/2015 | US8946194 One-step processing of hydrogels for mechanically robust and chemically desired features |
| 02/03/2015 | US8946193 Medical uses of glucans |
| 02/03/2015 | US8946192 Heat stable hyaluronic acid compositions for dermatological use |
| 02/03/2015 | US8946191 Imidated biopolymer adhesive and hydrogel |
| 02/03/2015 | US8946190 Medium-chain length fatty acids, salts and triglycerides in combination with gemcitabine for treatment of pancreatic cancer |
| 02/03/2015 | US8946189 Transplants |
| 02/03/2015 | US8946188 Anti-microbial agents and uses thereof |
| 02/03/2015 | US8946187 Materials and methods related to microRNA-21, mismatch repair, and colorectal cancer |
| 02/03/2015 | US8946185 Agent for suppressing expression of dominant allele |
| 02/03/2015 | US8946183 Compositions and methods for modulation of SMN2 splicing |
| 02/03/2015 | US8946182 Treatment of RNASE H1 related diseases by inhibition of natural antisense transcript to RNASE H1 |
| 02/03/2015 | US8946181 Treatment of interferon regulatory factor 8 (IRF8) related diseases by inhibition of natural antisense transcript to IRF8 |
| 02/03/2015 | US8946180 Means and methods for the specific modulation of target genes in the CNS and the eye and methods for their identification |
| 02/03/2015 | US8946178 Compositions and methods for treatment of pouchitis |
| 02/03/2015 | US8946175 Stabilized immunomodulatory oligonucleotides |
| 02/03/2015 | US8946173 Cancer cell death inducing agent having effects of potentiating anticancer drug against anticancer-drug-resistant cancer |
| 02/03/2015 | US8946170 Sustained release siRNA for ocular drug delivery |
| 02/03/2015 | US8946169 SPARC and methods of use thereof |
| 02/03/2015 | US8946168 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 02/03/2015 | US8946167 Pharmaceutical compositions containing plasma protein |
| 02/03/2015 | US8946164 Bioactive peptide |
| 02/03/2015 | US8946160 Nitric oxide amino acid esters for improving vascular circulation, and prophylaxis or treatment of a condition associated with impaired blood circulation |
| 02/03/2015 | US8946153 Fast dissolving pharmaceutical composition |
| 02/03/2015 | US8946127 Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms |
| 02/03/2015 | US8946124 Substituted 3-(biphenyl-3-yl)-8,8-difluoro-4-hydroxy-1-azaspiro[4.5]dec-3-en-2-ones for therapy and halogen-substituted spirocyclic ketoenols |
| 02/03/2015 | US8945929 Marker for determination of sensitivity to anti-cancer agent |
| 02/03/2015 | US8945922 Generating a mature NKT cell from a reprogrammed somatic cell with a T-cell antigen receptor α-chain region rearranged to uniform Va-Ja in a NKT-cell specific way |
| 02/03/2015 | US8945921 Modulating the production of neurons and/or oligodendrocytes from white matter progenitor cells |
| 02/03/2015 | US8945646 Method for manufacturing polymethoxyflavones that are highly stable over time and have reduced residual pesticide levels |
| 02/03/2015 | US8945636 Stabilized formulation comprising omega-3 fatty acids and use of the fatty acids for skin care and/or wound care |
| 02/03/2015 | US8945633 Pharmaceutical composition for preventing and treating inflammatory diseases containing an ethyl acetate fraction of dried extract of Trachelospermi caulis as an active ingredient, and method for producing the fraction |
| 02/03/2015 | US8945632 Methods and compositions for inhibiting the nuclear factor κB pathway |
| 02/03/2015 | US8945627 Micelles for the solubilization of gossypol |
| 02/03/2015 | US8945626 Preparation of pharmaceutical compositions |
| 02/03/2015 | US8945623 Compositions comprising biomembrane sealing agent for treatment of neuronal injury, and methods of use |
| 02/03/2015 | US8945622 Sustained release composition of therapeutic agent |
| 02/03/2015 | US8945621 Method for treating a patient at risk for developing an NSAID-associated ulcer |
| 02/03/2015 | US8945620 Solid pharmaceutical compositions containing pregabalin |
| 02/03/2015 | US8945619 Shell-and-core dosage form approaching zero-order drug release |
| 02/03/2015 | US8945616 Controlled release budesonide minitablets |
| 02/03/2015 | US8945615 Controlled release budesonide minitablets |
| 02/03/2015 | US8945614 Oral drug delivery system |
| 02/03/2015 | US8945612 Capsules containing high doses of levodopa for pulmonary use |
| 02/03/2015 | US8945611 Artificial oxygen carriers and use thereof |
| 02/03/2015 | US8945610 Condensation products based on bicyclic or polycyclic aromatics or heteroaromatics |
| 02/03/2015 | US8945608 Composition and method to alleviate joint pain |
| 02/03/2015 | US8945607 Electrolyte supplement and method of use |
| 02/03/2015 | US8945606 Oral adhering disc with dimple on adhering side |
| 02/03/2015 | US8945604 Ophthalmic device, and method of use thereof, for increasing ocular boundary lubrication |
| 02/03/2015 | US8945603 Sodium channel blocker delivery system with scleral lens |
| 02/03/2015 | US8945602 Porous photonic crystals for drug delivery to the eye |
| 02/03/2015 | US8945600 Methods of delivering pharmaceutical agents |
| 02/03/2015 | US8945599 Immobilized biologically active entities having a high degree of biological activity |
| 02/03/2015 | US8945596 Antimicrobial composition |
| 02/03/2015 | US8945593 Orally ingested metabolic enhancer in oral thin film container |
| 02/03/2015 | US8945592 Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same |
| 02/03/2015 | US8945591 Methods and compositions involving immunostimulatory oligodeoxynucleotides |
| 02/03/2015 | US8945590 Enhancement of an immune response by administration of a cationic lipid-DNA complex (CLDC) |
| 02/03/2015 | US8945575 Treatment of IgE-mediated disease |
| 02/03/2015 | US8945570 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers |
| 02/03/2015 | US8945557 Use of immunesuppressant receptor |
| 02/03/2015 | US8945551 Biopolymer hybrid gel-depot delivery system |
| 02/03/2015 | US8945549 Methods of treating antinociceptive tolerance |
| 02/03/2015 | US8945539 Enzyme and prebiotic combinations for enhancing probiotic efficacy |
| 02/03/2015 | US8945537 Process, tube and device for the preparation of wound healant composition |
| 02/03/2015 | US8945534 Controlled activation of the reuterin-production machinery of Lactobacillus |
| 02/03/2015 | US8945532 Anti-aging formulations |
| 02/03/2015 | US8945529 Biphasic lipid-vesicle compositions |
| 02/03/2015 | US8945527 Degradable compounds and methods of use thereof, particularly with particle replication in non-wetting templates |
| 02/03/2015 | US8945526 Amphiphilic substance, and drug delivery system and molecular imaging system using the same |
| 02/03/2015 | US8945518 Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions |
| 02/03/2015 | US8945516 Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
| 02/03/2015 | US8945510 Radiolabeled glutaminyl cyclase (QC) inhibitors and uses of same |
| 02/03/2015 | US8945108 Method of using vasoconstrictive agents during energy-based tissue therapy |
| 02/03/2015 | US8945063 Hazardous agent injection system |
| 02/03/2015 | US8945061 Otic formulations, methods and devices |
| 02/03/2015 | CA2814907C Crystalline form of 13-[(n-tert-butoxycarbonyl)-2'-o-hexanoyl-3-phenylisoserinyl]-10-deacetylbaccatin iii |
| 02/03/2015 | CA2812929C Compositions and methods for treating hyperproliferative disorders |
| 02/03/2015 | CA2784768C Tetrahydrotriazolopyridine compounds as selective mglu5 receptor potentiators useful for the treatment of schizophrenia |
| 02/03/2015 | CA2780547C Spiro-oxindole mdm2 antagonists |
| 02/03/2015 | CA2759546C A method and composition for the control of ectoparasites |
| 02/03/2015 | CA2758976C Chemosensory receptor ligand-based therapies |
| 02/03/2015 | CA2758774C Monoamine reuptake inhibitors |
| 02/03/2015 | CA2755084C Omega-3 enriched fish oil-in-water parenteral nutrition emulsions |
| 02/03/2015 | CA2751263C Novel saponin compounds, methods of preparation thereof, use thereof and pharmaceutical compositions |
| 02/03/2015 | CA2744705C Compositions and methods for treating hoof diseases |
| 02/03/2015 | CA2740570C Pharmaceutical composition for prevention and treatment of diabetes or obesity comprising a compound that inhibits activity of dipeptidyl peptidase-iv, and other antidiabetic or antiobesity agents as active ingredients |
| 02/03/2015 | CA2718277C Compositions and methods for transdermal oxybutynin therapy |
| 02/03/2015 | CA2705733C Reduced dose intravenous acetaminophen |
| 02/03/2015 | CA2679391C Method for treating and preventing arthritis |
| 02/03/2015 | CA2672298C Fused pyridine compounds useful in the prophylaxis or treatment of viral infections |